To test the hypothesis that STAT3 is a critical downstream effector of PKCζ in pancreatic cancer cells, we assessed whether expression of a constitutively active STAT3 construct (STAT3-C) could rescue the effects of PKCζ inhibition in Panc-1 cells. Here, STAT3 is linked to familial pancreatic carcinoma.